BioMarin CEO: There are biotech companies 'that probably should not be on the market today’ Yahoo Finance

1.9K views - 4 years ago

BioMarin CEO: Study results for hemophilia gene therapy are as 'good as we could hope' CNBC Television

2K views - 4 years ago

BioMarin Pharmaceutical CEO: Treating Hemophilia | Mad Money | CNBC CNBC

3.2K views - 7 years ago

Commitment to Patients: Kendra's Story BioMarin

587 views - 2 years ago

Jean-Jacques Bienaimé, Chief Executive Officer, BioMarin Pharmaceutical Inc. Biotechnology Innovation Organization

1.1K views - 13 years ago

BioMarin/Believe Limited Debut ‘Hemophilia: The Musical’ MultiVu

165 views - 7 years ago

Meet Gordon Vehar BioMarin

244 views - 3 years ago

BioMarin Pharmaceutical CEO on the company's drug pricing strategy CNBC Television

1.3K views - 3 years ago

2022 Love Lock Ceremony BioMarin

605 views - 3 years ago

Live Performance of Hemophilia: the Musical BioMarin

2.5K views - 7 years ago

Meet Sylvia Fong BioMarin

951 views - 4 years ago

Bone Growth in Achondroplasia BioMarin

22.2K views - 3 years ago

Prologue to Progress by BioMarin Hemophilia Federation of America

25 views - 4 years ago

Rare Disease Day 2021: Trees of Life Love Lock Ceremony BioMarin

183 views - 4 years ago

BioMarin - Show Compassion to Andrea Sloan Andis Army

911 views - 12 years ago

BioMarin Pharmaceutical Inc: Hal Brown Shining Star Award Zero Breast Cancer

177 views - 12 years ago

The Making of Hemophilia: the Musical BioMarin

641 views - 6 years ago

Fireside Chat With Jean-Jacques Bienaimé, Chief Executive Officer, BioMarin Biotechnology Innovation Organization

1.5K views - 13 years ago

CNBC Cures: Rare disease regulatory hurdles CNBC Television

655 views - 4 weeks ago

Biomarine BioPak 240R National Mine Health and Safety Academy

854 views - 3 years ago